Literature DB >> 1870635

Infantile Pompe's disease, lipid storage, and partial carnitine deficiency.

M A Verity1.   

Abstract

A diagnosis of infantile Pompe's disease (glycogenosis type II) was made by muscle biopsy on a 6-month-old infant boy seen with hypotonia, weakness, and developmental regression. Histochemistry and electron microscopy revealed a vacuolar myopathy with massive glycoge accumulation associated with increased neutral lipid as demonstrated on Oil Red O reactions. Pleomorphic, hypertrophic mitochondria with distortion of cristae and electron-dense deposits within the matrix were identified. Acid alpha-1,4-glucosidase activity was absent but associated with increased neutral maltase activity and a variable compensatory rise in activity of other lysosomal enzymes. Biochemical studies demonstrated low free carnitine, normal acylcarnitine, increased activity of carnitine palmityl and acyl transferases, and other enzymes of beta-oxidation with the notable exception of low normal beta-hydroxyacyl-CoA dehydrogenase activity. The explanation for the lipid accumulation is uncertain but is likely related to the combination of low carnitine concentration in muscle, low beta-hydroxyacyl CoA dehydrogenase, representing a rate limiting enzyme of beta-oxidation, and nonspecific defective mitochondrial function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1870635     DOI: 10.1002/mus.880140509

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  13 in total

1.  Glycogen storage disease type IIa.

Authors:  V Gharpure; K Raghavan; M Mehta; A Kalgutkar
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

Review 2.  Lysosomal storage disorders in the newborn.

Authors:  Orna Staretz-Chacham; Tess C Lang; Mary E LaMarca; Donna Krasnewich; Ellen Sidransky
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

Review 3.  Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten.

Authors:  Nina Raben; Amanda Wong; Evelyn Ralston; Rachel Myerowitz
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-01-17       Impact factor: 3.908

4.  Lipin-1 regulates autophagy clearance and intersects with statin drug effects in skeletal muscle.

Authors:  Peixiang Zhang; M Anthony Verity; Karen Reue
Journal:  Cell Metab       Date:  2014-06-12       Impact factor: 27.287

Review 5.  Cardiomyocyte autophagy: remodeling, repairing, and reconstructing the heart.

Authors:  Dian J Cao; Thomas G Gillette; Joseph A Hill
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

6.  Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle.

Authors:  Irina Kramerova; Elena Kudryashova; Benjamin Wu; Sean Germain; Krista Vandenborne; Nadine Romain; Ronald G Haller; M Anthony Verity; Melissa J Spencer
Journal:  Hum Mol Genet       Date:  2009-05-29       Impact factor: 6.150

7.  Autophagy in the myocardium: Dying for survival?

Authors:  Shyamal K Goswami; Dipak K Das
Journal:  Exp Clin Cardiol       Date:  2006

8.  Regulation and role of glycophagy in skeletal muscle energy metabolism.

Authors:  Timothy D Heden; Lisa S Chow; Curtis C Hughey; Douglas G Mashek
Journal:  Autophagy       Date:  2021-09-10       Impact factor: 13.391

9.  Mitochondrial Copy Number and D-Loop Variants in Pompe Patients.

Authors:  Fatemeh Bahreini; Massoud Houshmand; Mohammad Hossein Modaresi; Hassan Tonekaboni; Shahriar Nafissi; Ferdoss Nazari; Seyed Mohammad Akrami
Journal:  Cell J       Date:  2016-08-24       Impact factor: 2.479

10.  The involvement of lysosomes in myocardial aging and disease.

Authors:  Alexei Terman; Tino Kurz; Bertil Gustafsson; Ulf T Brunk
Journal:  Curr Cardiol Rev       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.